final analysis of the alpine trial: zanubrutinib vs ibrutinib in r/r cll
Published 1 year ago • 376 plays • Length 1:05Download video MP4
Download video MP3
Similar videos
-
1:00
ash 2022 lba: results from final analysis of alpine - zanubrutinib vs ibrutinib for r/r cll/sll
-
1:55
the alpine trial shows improved outcomes with zanubrutinib versus ibrutinib in r/r cll
-
1:43
extended follow-up of the alpine trial: superior outcomes with zanubrutinib in r/r cll/sll
-
1:13
alpine trial update: zanubrutinib continues to show superior efficacy to ibrutinib in cll
-
2:26
the value of zanubrutinib in the cll treatment armamentarium & sequoia trial updates
-
1:11
recent updates from the alpine trial
-
11:30
cll patient story - diane george
-
12:49
3mensio ct pre-case planning: valve-in-valve tavr in homograft
-
5:00
venetoclax-obinutuzumab is superior to chemoimmunotherapy in frontline cll: updates from gaia/cll13
-
2:24
interim analysis of the alpine study
-
2:12
results from a phase i trial of tinostamustine in patients with r/r classical hl
-
2:58
results of a phase ib study of ibrutinib obinutuzumab in r/r cll
-
1:55
key updates from the interim analysis of the flair trial
-
0:45
key trials in cll and designing a concept for treatment
-
1:44
updates from the phase ii animate trial of nivolumab in r/r chl
-
3:13
analysis of the eortc/fil/lysa h10 and rapid trials
-
2:08
updates from gaia/cll13 trial: impact of complex karyotype on outcomes in cll
-
7:55
clinical trials of fixed duration treatments & novel targets in cll
-
1:18
updates from current cll clinical trials
-
2:14
long-term follow-up results from the rathl trial: response-adapted treatment for advanced stage hl
-
0:54
insights into the zuma-23 trial: axi-cel in frontline high-risk lbcl
-
3:06
updated pfs results of the gaia/cll13 trial